368 related articles for article (PubMed ID: 37257253)
1. Activation of p53-regulated pro-survival signals and hypoxia-independent mitochondrial targeting of TIGAR by human papillomavirus E6 oncoproteins.
Yapindi L; Bowley T; Kurtaneck N; Bergeson RL; James K; Wilbourne J; Harrod CK; Hernandez BY; Emerling BM; Yates C; Harrod R
Virology; 2023 Aug; 585():1-20. PubMed ID: 37257253
[TBL] [Abstract][Full Text] [Related]
2. The human T-cell leukemia virus type-1 p30
Romeo M; Hutchison T; Malu A; White A; Kim J; Gardner R; Smith K; Nelson K; Bergeson R; McKee R; Harrod C; Ratner L; Lüscher B; Martinez E; Harrod R
Virology; 2018 May; 518():103-115. PubMed ID: 29462755
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
4. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
[TBL] [Abstract][Full Text] [Related]
6. Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.
Wang H; Mo P; Ren S; Yan C
J Biol Chem; 2010 Apr; 285(17):13201-10. PubMed ID: 20167600
[TBL] [Abstract][Full Text] [Related]
7. The role of TP53 in Cervical carcinogenesis.
Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
[TBL] [Abstract][Full Text] [Related]
8. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
9. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM
J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53.
DasGupta T; Nweze EI; Yue H; Wang L; Jin J; Ghosh SK; Kawsar HI; Zender C; Androphy EJ; Weinberg A; McCormick TS; Jin G
Oncotarget; 2016 May; 7(19):27430-44. PubMed ID: 27034006
[TBL] [Abstract][Full Text] [Related]
11. Hyperactivation of p53 using CRISPRa kills human papillomavirus-driven cervical cancer cells.
Idres YM; Lai AJ; McMillan NAJ; Idris A
Virus Genes; 2023 Apr; 59(2):312-316. PubMed ID: 36474086
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Species from Vaginal Microbiota Differently Affect the Production of the E6 and E7 Oncoproteins and of p53 and p-Rb Oncosuppressors in HPV16-Infected Cells.
Nicolò S; Antonelli A; Tanturli M; Baccani I; Bonaiuto C; Castronovo G; Rossolini GM; Mattiuz G; Torcia MG
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108333
[TBL] [Abstract][Full Text] [Related]
13. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
14. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress.
Kimata M; Matoba S; Iwai-Kanai E; Nakamura H; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Mita Y; Okigaki M; Ikeda K; Tatsumi T; Matsubara H
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1908-16. PubMed ID: 20935145
[TBL] [Abstract][Full Text] [Related]
15. HPV-CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing.
Zhi W; Wei Y; Lazare C; Meng Y; Wu P; Gao P; Lin S; Peng T; Chu T; Liu B; Ding W; Cao C; Wu P
J Med Virol; 2023 Jan; 95(1):e28009. PubMed ID: 35854676
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
17. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
18. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling.
Sharma S; Munger K
mBio; 2020 Jun; 11(3):. PubMed ID: 32546626
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]